Optimal Therapy for Early-Stage Hodgkin's Lymphoma: Risk Adapting, Response Adapting, and Role of Radiotherapy.

Filippi, Andrea Riccardo; Levis, Mario; Parikh, Rahul; Hoppe, Bradford

Filippi, Andrea Riccardo; Levis, Mario; Parikh, Rahul; Hoppe, Bradford.

Affiliation

Filippi AR; Department of Oncology, San Luigi Gonzaga University Hospital, University of Torino, Regione Gonzole 10, 10043, Orbassano, Turin, Italy. andreariccardo.filippi@unito.it.
Levis M; Department of Oncology, San Luigi Gonzaga University Hospital, University of Torino, Regione Gonzole 10, 10043, Orbassano, Turin, Italy.
Parikh R; Department of Radiation Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, USA.
Hoppe B; Department of Radiation Oncology, University of Florida, Gainesville, USA.

Curr Oncol Rep ; 19(5): 34, 2017 May.

Article in En | MEDLINE | ID: mdl-28365830

Subject(s)

Hodgkin Disease/drug therapy; Hodgkin Disease/radiotherapy; Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Combined Modality Therapy; Dacarbazine/therapeutic use; Disease-Free Survival; Doxorubicin/therapeutic use; Hodgkin Disease/pathology; Humans; Neoplasm Staging

Key words

Early stage; Hodgkin's lymphoma; Proton therapy; Radiotherapy

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hodgkin Disease Type of study: Etiology_studies / Risk_factors_studies Limits: Humans Language: En Journal: Curr Oncol Rep Journal subject: NEOPLASIAS Year: 2017 Type: Article Affiliation country: Italy

Fulltext

XML

PubMed Links

Search on Google